Clinical Trial Detail

NCT ID	NCT02713529
Title	Safety Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer
Recruitment	Completed
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	Amgen
Indications	lung non-small cell carcinoma colorectal cancer pancreatic cancer
Therapies	AMG 820 + Pembrolizumab
Age Groups:	adult